Are Plant-Based Meat Substitutes Really Better For The Heart Than Meat Options?

Translate to Spanish or other 102 languages!

 As plant-based meat substitutes gain popularity, researchers in Singapore have conducted a study comparing their effects on health to those of traditional meats, with a specific focus on heart health and diabetes risk. Image for illustration purposes
As plant-based meat substitutes gain popularity, researchers in Singapore have conducted a study comparing their effects on health to those of traditional meats, with a specific focus on heart health and diabetes risk. Image for illustration purposes
- Advertisement -
  • As plant-based meat substitutes gain popularity, researchers in Singapore have conducted a study comparing their effects on health to those of traditional meats, with a specific focus on heart health and diabetes risk.
  • The research, involving 89 adults at risk for type 2 diabetes, found no significant heart health benefits of plant-based meat diets over those including animal meat, challenging the notion that these alternatives offer the same health advantages as whole plant-based diets. 
  • Highlighting the nutritional differences between plant-based meat analogues and animal meats, the findings suggest a need for the food industry to develop nutritionally enhanced and environmentally sustainable plant-based meat substitutes.

In new research, published in The American Journal of Clinical Nutrition, scientists looked at how diets containing real meat compare to those using plant-based meat alternatives, especially in terms of cardiovascular health and diabetes risk.

Follow the link Below to read the full story om Medical News Today:

https://www.medicalnewstoday.com/articles/are-plant-based-meat-substitutes-really-better-for-the-heart-than-meat-options?slot_pos=article_1&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-04-15&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.
- Advertisement -